CARNITEN

Levocarnitine USP

Composition : Levocarnitine USP 330mg Tablet.

Indication : Levocarnitine supplementation may benefit individuals with the following conditions :

1. Congestive Heart Failure (CHF)

2. Hypercholesterolemia

3. Intermittent claudication

4. Athletic performance

5. Weight loss

6. Chronic Obstructive Pulmonary Disease (COPD)

7. Alzheimer's disease

8. Mild depression

9. Hyperthyroidism

10. Peyronie's disease &

11. Male infertility.

Dosage and administration : Adults : The recommended dosage for adult is 990mg (3 tablets) two or three times a day depending on clinical response. Infants and children : The recommended oral dosage for infants and children is between 50 -100mg kg/day in divided doses, with a maximum of 3g/day. Dosage should begin at 50mg/kg/day. The exact dosage will depend on clinical response. Or, as directed by the registered physician.

Pregnancy and lactation : Pregnancy Category B by FDA.

Packing : Carniten : 7 x 7's tablets in blister pack.

Prescribing Description

Related Products

© Copyright Drug International Ltd. 2024 Designed and Developed by ATI Limited.